Multicenter phase II study of gemcitabine in previously untreated patients with advanced epithelial ovarian cancer

CR Underhill, FX Parnis, MS Highley, J. Ahern, PG Harper, H. Hansen, B. Lund, P. Dombernowsky, F. Hirsch, M. Hansen, J. Carmichael, Hywel C. Williams

Research output: Contribution to journalJournal articleResearchpeer-review

12 Citations (Scopus)
Original languageEnglish
JournalAnti-Cancer Drugs
Volume12
Issue number8
Pages (from-to)647-652
Number of pages6
ISSN0959-4973
DOIs
Publication statusPublished - 1 Sep 2001
Externally publishedYes

Keywords

  • epithelial ovarian cancer
  • gemcitabine
  • phase II
  • CELL LUNG-CANCER
  • STAGE-III
  • PACLITAXEL
  • CISPLATIN
  • TAXOL
  • AGENT
  • Oncology
  • Pharmacology & Pharmacy

Cite this